carcinoid

You have access
¹⁸F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1865-1870; DOI: https://doi.org/10.2967/jnumed.122.263984
You have access
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with ¹³¹I-MIBG
Ari Kane, Matthew P. Thorpe, Michael A. Morse, Brandon A. Howard, Jorge D. Oldan, Jason Zhu, Terence Z. Wong, Neil A. Petry, Robert Reiman and Salvador Borges-Neto

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1708-1713; DOI: https://doi.org/10.2967/jnumed.117.202150
You have access
Safety and Efficacy of ⁶⁸Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
Stephen A. Deppen, Eric Liu, Jeffrey D. Blume, Jeffrey Clanton, Chanjuan Shi, Laurie B. Jones-Jackson, Vipul Lakhani, Richard P. Baum, Jordan Berlin, Gary T. Smith, Michael Graham, Martin P. Sandler, Dominique Delbeke and Ronald C. Walker

Journal of Nuclear Medicine May 1, 2016, 57 (5) 708-714; DOI: https://doi.org/10.2967/jnumed.115.163865

Main menu